Association of ABCC2 polymorphisms with platinum-based chemotherapy response and severe toxicity in non-small cell lung cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Association of ABCC2 polymorphisms with platinum-based chemotherapy response and severe toxicity in non-small cell lung cancer patients

Published:2011-05 Issue:2 Volume:72 Page:238-243
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Han Baohui,Gao Ge,Wu Wenting,Gao Zhiqiang,Zhao Xueying,Li Ling,Qiao Rong,Chen Hongyan,Wei Qingyi,Wu Jinchang,Lu Daru

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference40 articles.

1. Estimates of the worldwide incidence of 25 major cancers in 1990;Parkin;International Journal of Cancer,1999

2. Revisions in the international system for staging lung cancer;Mountain;Chest,1997

3. The treatment of advanced non-small cell lung cancer;Spiro;Current Opinion in Pulmonary Medicine,2005

4. Small cell lung cancer;Simon;Chest,2003

5. The role of p53 in treatment responses of lung cancer;Viktorsson;Biochemical and Biophysical Research Communications,2005

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic polymorphisms and platinum-induced hematological toxicity: a systematic review;Frontiers in Pharmacology;2024-08-21

2. Genetic polymorphisms as potential pharmacogenetic biomarkers for platinum-based chemotherapy in non-small cell lung cancer;Molecular Biology Reports;2024-01-13

3. A case-control study of a combination of single nucleotide polymorphisms and clinical parameters to predict clinically relevant toxicity associated with fluoropyrimidine and platinum-based chemotherapy in gastric cancer;BMC Cancer;2021-09-16

4. Predictive value of ERCC2, ABCC2 and MMP2 of response and long-term survival in locally advanced head and neck cancer patients treated with chemoradiotherapy;Cancer Chemotherapy and Pharmacology;2021-07-26

5.

miR-424-3p Contributes to the Malignant Progression and Chemoresistance of Gastric Cancer

;OncoTargets and Therapy;2020-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3